MPC vs SPRY · P/E 16, rev $138.86B vs rev $89.1M
Marathon Petroleum Corp (MPC) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the MPC and SPRY stock pages for the full models.
Not investment advice.